Cote d'Ivoire vs Kyrgyzstan: Treatment success rate for patients treated for MDR-TB
Cote d'Ivoire
75.0%
in 2022
Kyrgyzstan
75.0%
in 2022
Cote d'Ivoire rank
70th
Kyrgyzstan rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Cote d'Ivoire
- Kyrgyzstan
How they compare
Cote d'Ivoire currently reports 75.0% against 75.0% in Kyrgyzstan, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2013 it was Cote d'Ivoire ahead.
Cote d'Ivoire ranks 70th and Kyrgyzstan ranks 70th of 163 countries.
Cote d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.4% | 58.4% | 19.0% | Cote d'Ivoire |
| 2020s | 76.0% | 74.0% | 2.0% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cote d'Ivoire or Kyrgyzstan?
- Cote d'Ivoire, at 75.0% against 75.0% in Kyrgyzstan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cote d'Ivoire and Kyrgyzstan?
- 0.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Kyrgyzstan?
- 10 years are reported by both, from 2013 to 2022.
- How do Cote d'Ivoire and Kyrgyzstan rank globally for treatment success rate for patients treated for mdr-tb?
- Cote d'Ivoire ranks 70th and Kyrgyzstan ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.